Myocardial Infarction in the Elderly

Overview

Journal Aging Dis

Specialty Geriatrics

Date 2012 Mar 8

PMID 22396870

Citations 24

Authors

Amelia Carro

Juan Carlos Kaski

Affiliations

Soon will be listed here.

Abstract

Advances in pharmacological treatment and effective early myocardial revascularization have -in recent years- led to improved clinical outcomes in patients with acute myocardial infarction (AMI). However, it has been suggested that compared to younger subjects, elderly AMI patients are less likely to receive evidence-based treatment, including myocardial revascularization therapy. Several reasons have been postulated to explain this trend, including uncertainty regarding the true benefits of the interventions commonly used in this setting as well as increased risk mainly associated with comorbidities. The diagnosis, management, and post-hospitalization care of elderly patients presenting with an acute coronary syndrome pose many difficulties at present. A complex interplay of variables such as comorbidities, functional and socioeconomic status, side effects associated with multiple drug administration, and individual biologic variability, all contribute to creating a complex clinical scenario. In this complex setting, clinicians are often required to extrapolate evidence-based results obtained in cardiovascular trials from which older patients are often, implicitly or explicitly, excluded. This article reviews current recommendations regarding management of AMI in the elderly.

Citing Articles

Ethnic disparities in STEMI outcomes among older adults: a comparative study of bedouins and jews.

Shashar S, Zeldetz V, Shalev A, Barret O, Press Y, Shamia D Int J Equity Health. 2025; 24(1):66.

PMID: 40065403 PMC: 11895306. DOI: 10.1186/s12939-025-02427-0.

Epidemiologic trends and characteristics of cancer-related emergency department visits of older patients living with cancer in South Korea.

Ko J, Lee S, Yoo S, Kim K, Cho B Sci Rep. 2025; 15(1):4767.

PMID: 39922880 PMC: 11807093. DOI: 10.1038/s41598-025-89104-y.

Management of Acute Coronary Syndrome in Elderly Patients: A Narrative Review through Decisional Crossroads.

Verardi R, Iannopollo G, Casolari G, Nobile G, Capecchi A, Bruno M J Clin Med. 2024; 13(20).

PMID: 39457985 PMC: 11508245. DOI: 10.3390/jcm13206034.

Evolution of REperfusion Strategies and impact on mortality in Old and Very OLD STEMI patients. The RESOVOLD-e-MUST study.

Lapostolle F, Petrovic T, Moiteaux B, Loyeau A, Boche T, Kadji Kalabang R Age Ageing. 2024; 53(1).

PMID: 38167925 PMC: 10762506. DOI: 10.1093/ageing/afad215.

Impact of age and sex on myelopoiesis and inflammation during myocardial infarction.

Kanuri B, Biswas P, Dahdah A, Murphy A, Nagareddy P J Mol Cell Cardiol. 2024; 187:80-89.

PMID: 38163742 PMC: 10922716. DOI: 10.1016/j.yjmcc.2023.11.011.

References

Thompson C, Buller C, Sleeper L, Antonelli T, WEBB J, Jaber W . Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we use emergently revascularize Occluded Coronaries in cardiogenic shocK?. J Am Coll Cardiol. 2000; 36(3 Suppl A):1104-9. DOI: 10.1016/s0735-1097(00)00846-9. View

Jeremias A, Gibson C . Narrative review: alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded. Ann Intern Med. 2005; 142(9):786-91. DOI: 10.7326/0003-4819-142-9-200505030-00015. View

Menon V, WEBB J, Hillis L, Sleeper L, Abboud R, Dzavik V . Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK?. J Am Coll Cardiol. 2000; 36(3 Suppl A):1110-6. DOI: 10.1016/s0735-1097(00)00878-0. View

Mehta R, Granger C, Alexander K, Bossone E, White H, Sketch Jr M . Reperfusion strategies for acute myocardial infarction in the elderly: benefits and risks. J Am Coll Cardiol. 2005; 45(4):471-8. DOI: 10.1016/j.jacc.2004.10.065. View

Curtis J, Alexander J, Huang Y, Wallentin L, Verheugt F, Armstrong P . Efficacy and safety of two unfractionated heparin dosing strategies with tenecteplase in acute myocardial infarction (results from Assessment of the Safety and Efficacy of a New Thrombolytic Regimens 2 and 3). Am J Cardiol. 2004; 94(3):279-83. DOI: 10.1016/j.amjcard.2004.04.019. View

Wilson P, DAgostino R, Levy D, Belanger A, Silbershatz H, Kannel W . Prediction of coronary heart disease using risk factor categories. Circulation. 1998; 97(18):1837-47. DOI: 10.1161/01.cir.97.18.1837. View

Sugiura M, Hiraoka K, Ohkawa S . Severity of coronary sclerosis in the aged: a pathological study in 968 consecutive autopsy cases. Jpn Heart J. 1976; 17(4):471-8. DOI: 10.1536/ihj.17.471. View

Gurwitz J, Col N, Avorn J . The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA. 1992; 268(11):1417-22. View

Antman E, Hand M, Armstrong P, Bates E, Green L, Halasyamani L . 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2008; 51(2):210-47. DOI: 10.1016/j.jacc.2007.10.001. View

10.

Burns T, Klima M, Teasdale T, Kasper K . Morphometry of the aging heart. Mod Pathol. 1990; 3(3):336-42. View

11.

Thiemann D, Coresh J, Schulman S, Gerstenblith G, Oetgen W, Powe N . Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years. Circulation. 2000; 101(19):2239-46. DOI: 10.1161/01.cir.101.19.2239. View

12.

White H . Thrombolytic therapy in the elderly. Lancet. 2001; 356(9247):2028-30. DOI: 10.1016/S0140-6736(00)03397-3. View

13.

Murray C, Lopez A . Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet. 1997; 349(9061):1269-76. DOI: 10.1016/S0140-6736(96)07493-4. View

14.

Becker R, Hochman J, Cannon C, Spencer F, Ball S, Rizzo M . Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists: observations from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction 9 Study. J Am Coll Cardiol. 1999; 33(2):479-87. DOI: 10.1016/s0735-1097(98)00582-8. View

15.

Eggers K, Lind L, Venge P, Lindahl B . Will the universal definition of myocardial infarction criteria result in an overdiagnosis of myocardial infarction?. Am J Cardiol. 2009; 103(5):588-91. DOI: 10.1016/j.amjcard.2008.11.007. View

16.

Wallentin L, Goldstein P, Armstrong P, Granger C, Adgey A, Arntz H . Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS.... Circulation. 2003; 108(2):135-42. DOI: 10.1161/01.CIR.0000081659.72985.A8. View

17.

Ryan T, Antman E, Brooks N, Califf R, Hillis L, Hiratzka L . 1999 update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and Recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.... Circulation. 1999; 100(9):1016-30. DOI: 10.1161/01.cir.100.9.1016. View

18.

Morrow D, Antman E, Charlesworth A, Cairns R, Murphy S, de Lemos J . TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation. 2000; 102(17):2031-7. DOI: 10.1161/01.cir.102.17.2031. View

19.

de Jaegere P, Arnold A, Balk A, Simoons M . Intracranial hemorrhage in association with thrombolytic therapy: incidence and clinical predictive factors. J Am Coll Cardiol. 1992; 19(2):289-94. DOI: 10.1016/0735-1097(92)90480-b. View

20.

Keeley E, Boura J, Grines C . Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003; 361(9351):13-20. DOI: 10.1016/S0140-6736(03)12113-7. View